Nov 14, 2024, 01:00 by User Not Found

Clinical Research News | Perinatal pathologists are calling for placental pathology to be incorporated into prospective clinical trials so they can start telling clinical providers what the findings in their reports mean. For want of funding and the relevant diagnostic expertise, the placenta has long been a woefully under-investigated organ that could be providing critical insights on pregnancy-related conditions like preeclampsia and preterm birth that are currently defined solely based on a clinical diagnosis.

Nov 13, 2024, 08:40 by

Nov 13, 2024, 08:40 by

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

Nov 13, 2024, 08:40 by

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Nov 12, 2024, 08:17 by

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

Nov 12, 2024, 01:00 by User Not Found

Clinical Research News | Last week at SCOPE Europe, industry leaders took on the impact of AI regulation—particularly the European Union's AI Act—on the clinical research and life sciences sectors. Moderated by BioSpace’s Lori Ellis, the panelists included Firas Abdessalem of Sanofi, Christopher Hart of Foley Hoag, Ricardo Gaminha Pacheco of InSilico Medicine, and Artemy Shumskiy of Latvian VC company LongeVC. Together they discussed how the EU’s AI Act is likely to impact innovation, funding, and partnerships in the life sciences.

Nov 11, 2024, 08:24 by

Octalsoft, a global leader in clinical trial and healthcare technology solutions, is proud to announce its recognition as a Times Gujarat Icon 2024 Award winner, acknowledging the company’s exceptional contributions to the technology and healthcare sectors.

Nov 11, 2024, 08:24 by

MaxisIT has launched DTect AI, a new AI-driven solution within its eXchange Data Management Workbench, designed to improve data quality in clinical trials. DTect AI uses advanced models for real-time anomaly detection, data quality scoring, and intelligent recommendations, integrating seamlessly with sources like EDCs and LABs. By leveraging machine learning and natural language processing, it adapts to data patterns to ensure accuracy and accelerate data management. This solution sets a new industry standard for clinical data integrity and speeds up the drug development process, helping bring treatments to patients more efficiently.

Nov 8, 2024, 01:00 by User Not Found

Clinical Research News | Ensuring clinical trial participants adhere to study protocols is essential for reliable clinical trial results. If participants aren't consistent with their participation, the data collected won't accurately reflect the effectiveness of a treatment or therapy. Poor adherence can slow down or even derail clinical breakthroughs.

Nov 7, 2024, 10:45 by

The MAP Group acquires German market access consultancy as it continues to expand internationally.

Nov 7, 2024, 01:00 by User Not Found

Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz gives you the latest news on a study for AI system for drug repurposing, a window trial for a new triple-negative breast cancer treatment, Jill Pellegrino’s transition from CVS to AutoCruitment, publication bias with industry sponsored studies for psychiatric drugs, and more.

Nov 4, 2024, 01:00 by User Not Found

Clinical Research News | A profound shift is underway: one that positions patients not merely as recipients of clinical care but as active participants and collaborators in clinical research. A panel at last week’s SCOPE Summit Europe took on this challenge.

Oct 30, 2024, 10:22 by User Not Found

Clinical Research News | Clinical Research News and ClinEco announced three Best of Show winners today at the 2024 SCOPE Europe conference in Barcelona, Spain. The winning companies that submitted their products include Anju Software, Greenphire, and Medidata.

Oct 30, 2024, 01:00 by User Not Found

Clinical Research News | IQVIA introduces IQVIA AI Assistant; DHL Express and Thermo Fisher Scientific join forces to drive more sustainable clinical research services; Withings Health Solutions announces a first-of-its-kind cellular blood pressure monitor; and more.

Oct 29, 2024, 08:24 by

Takara Bio Europe has announced the expansion of its Gothenburg facility, with the addition of a custom manufacturing lab. This new facility now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes, servicing the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across EMEA, producing up to 600,000 reactions per week. With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.

Oct 29, 2024, 08:24 by

Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer.

Oct 29, 2024, 01:00 by User Not Found

Clinical Research News | Seaport Therapeutics plans to advance their therapeutic candidate SPT-300, an oral prodrug of allopregnanolone; Purespring Therapeutics will initiate a clinical trial for IgAN, a common, chronic kidney disease primarily affecting young adults; and more.

Oct 28, 2024, 08:05 by

RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.

Oct 25, 2024, 01:00 by User Not Found

Clinical Research News | In clinical research, one ongoing challenge continues to persist: a lack of diverse representation. While the root cause stems from a combination of limited access and endemic mistrust of the health care system among certain communities, the outcome is that large pockets of communities are often excluded from studies, even in key areas where they are disproportionately affected by diseases such as diabetes, heart disease, and certain forms of cancer.

Oct 24, 2024, 08:09 by

CluePoints, provider of leading statistical and AI-driven software solutions, has been recognized for its impressive growth at the BVA Private Equity Awards.